Founded in 2003, Integrity Bio's mission is to provide help to those who strive to save or improve the quality of human life by providing them the integrated services of Formulation Development, GMP Fill Finish Services, and Innovative Drug Delivery technologies.
“Byeong has been an inspirational leader for all of us, and after nearly two decades at the helm of Integrity Bio has now been thinking ahead about how to position the company for the future,” said Mr. Reilly. “It's been a real privilege for me to work with Integrity Bio over the last eight years, and I’m excited to take the helm now as we have some big things planned for the coming year and beyond. I share Byeong’s optimism for the firm’s bright future in this growing field.”
“The timing is right to hand over the reins,” commented Byeong Chang. “Having worked very closely together, I have tremendous trust and confidence in Michael and believe he is the right person to lead this next phase of our growth.”
During his time at Integrity Bio, Mr. Reilly has served as VP of Business Development and led the company’s Excelse Bio high-concentration formulation technology division. Prior to that, he held senior positions at Baxter BioScience and Amgen.
If you would like more information, contact Brendon Keiser at 805-445-8422 x154 or brendon.keiser@integritybio.com
